Commonwealth Equity Services’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Sell |
4,710
-296
| -6% | -$64.8K | ﹤0.01% | 2533 |
|
|
2025
Q1 | $1.12M | Buy |
5,006
+475
| +10% | +$106K | ﹤0.01% | 2360 |
|
|
2024
Q4 | $1.48M | Sell |
4,531
-512
| -10% | -$168K | ﹤0.01% | 2087 |
|
|
2024
Q3 | $1.51M | Sell |
5,043
-913
| -15% | -$274K | ﹤0.01% | 2028 |
|
|
2024
Q2 | $1.96M | Sell |
5,956
-343
| -5% | -$113K | ﹤0.01% | 1798 |
|
|
2024
Q1 | $2.49M | Sell |
6,299
-52
| -0.8% | -$20.6K | ﹤0.01% | 1632 |
|
|
2023
Q4 | $2.24M | Sell |
6,351
-89
| -1% | -$31.3K | ﹤0.01% | 1622 |
|
|
2023
Q3 | $2.42M | Buy |
6,440
+58
| +0.9% | +$21.8K | 0.01% | 1480 |
|
|
2023
Q2 | $2.44M | Sell |
6,382
-1,739
| -21% | -$665K | 0.01% | 1494 |
|
|
2023
Q1 | $2.81K | Sell |
8,121
-822
| -9% | -$285 | 0.01% | 1338 |
|
|
2022
Q4 | $2.1M | Sell |
8,943
-815
| -8% | -$192K | 0.01% | 1462 |
|
|
2022
Q3 | $2.4M | Buy |
9,758
+287
| +3% | +$70.6K | 0.01% | 1307 |
|
|
2022
Q2 | $2.86M | Sell |
9,471
-94
| -1% | -$28.4K | 0.01% | 1207 |
|
|
2022
Q1 | $3.93M | Sell |
9,565
-5,015
| -34% | -$2.06M | 0.01% | 1085 |
|
|
2021
Q4 | $6.84M | Buy |
14,580
+1,530
| +12% | +$718K | 0.02% | 774 |
|
|
2021
Q3 | $5.54M | Buy |
13,050
+2,321
| +22% | +$985K | 0.01% | 815 |
|
|
2021
Q2 | $3.85M | Buy |
10,729
+5,378
| +101% | +$1.93M | 0.01% | 998 |
|
|
2021
Q1 | $1.51M | Sell |
5,351
-417
| -7% | -$117K | ﹤0.01% | 1510 |
|
|
2020
Q4 | $1.63M | Buy |
5,768
+917
| +19% | +$260K | ﹤0.01% | 1339 |
|
|
2020
Q3 | $1.33M | Sell |
4,851
-123
| -2% | -$33.8K | ﹤0.01% | 1325 |
|
|
2020
Q2 | $1.13M | Buy |
4,974
+1,335
| +37% | +$303K | ﹤0.01% | 1355 |
|
|
2020
Q1 | $554K | Sell |
3,639
-146
| -4% | -$22.2K | ﹤0.01% | 1630 |
|
|
2019
Q4 | $569K | Buy |
3,785
+120
| +3% | +$18K | ﹤0.01% | 1810 |
|
|
2019
Q3 | $519K | Sell |
3,665
-66
| -2% | -$9.35K | ﹤0.01% | 1796 |
|
|
2019
Q2 | $466K | Buy |
3,731
+25
| +0.7% | +$3.12K | ﹤0.01% | 1850 |
|
|
2019
Q1 | $408K | Sell |
3,706
-150
| -4% | -$16.5K | ﹤0.01% | 1914 |
|
|
2018
Q4 | $378K | Buy |
3,856
+208
| +6% | +$20.4K | ﹤0.01% | 1853 |
|
|
2018
Q3 | $450K | Buy |
3,648
+1,220
| +50% | +$150K | ﹤0.01% | 1854 |
|
|
2018
Q2 | $241K | Sell |
2,428
-193
| -7% | -$19.2K | ﹤0.01% | 2309 |
|
|
2018
Q1 | $231K | Sell |
2,621
-184
| -7% | -$16.2K | ﹤0.01% | 2285 |
|
|
2017
Q4 | $277K | Buy |
2,805
+94
| +3% | +$9.28K | ﹤0.01% | 2100 |
|
|
2017
Q3 | $261K | Buy |
2,711
+28
| +1% | +$2.7K | ﹤0.01% | 2079 |
|
|
2017
Q2 | $254K | Buy |
+2,683
| New | +$254K | ﹤0.01% | 2042 |
|
|
2017
Q1 | – | Sell |
-2,595
| Closed | -$220K | – | 2482 |
|
|
2016
Q4 | $220K | Buy |
+2,595
| New | +$220K | ﹤0.01% | 1988 |
|